pBXPHM3-NB-D6
(Plasmid
#167989)
-
Purposeexpression of a nanobody against rat PepT2 as a n terminal MBP fusion
-
Depositing Lab
-
Sequence Information
-
Sequences (1) — Accept Affinity Reagent Sequence Policy
-
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 167989 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBXPHM3
- Backbone size w/o insert (bp) 5200
- Total vector size (bp) 5600
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameNanobodyD6
-
Speciesllama
-
Insert Size (bp)393
- Promoter pBAD
-
Tag
/ Fusion Protein
- His-MBP (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BspQI (not destroyed)
- 3′ cloning site BspQI (not destroyed)
- 5′ sequencing primer MBP-F
- 3′ sequencing primer pBad-R (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBXPHM3-NB-D6 was a gift from Simon Newstead (Addgene plasmid # 167989 ; http://n2t.net/addgene:167989 ; RRID:Addgene_167989) -
For your References section:
Cryo-EM structure of PepT2 reveals structural basis for proton-coupled peptide and prodrug transport in mammals. Parker JL, Deme JC, Wu Z, Kuteyi G, Huo J, Owens RJ, Biggin PC, Lea SM, Newstead S. Sci Adv. 2021 Aug 25;7(35). pii: 7/35/eabh3355. doi: 10.1126/sciadv.abh3355. Print 2021 Aug. 10.1126/sciadv.abh3355 PubMed 34433568